Intuitive Surgical, Inc. $ISRG Shares Sold by Penobscot Investment Management Company Inc.

Penobscot Investment Management Company Inc. lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.6% during the third quarter, HoldingsChannel.com reports. The fund owned 8,830 shares of the medical equipment provider’s stock after selling 1,276 shares during the period. Penobscot Investment Management Company Inc.’s holdings in Intuitive Surgical were worth $3,591,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Bank of America Corp DE boosted its holdings in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at $1,335,753,000. Amundi increased its holdings in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after purchasing an additional 1,027,475 shares during the period. Finally, Janus Henderson Group PLC increased its holdings in shares of Intuitive Surgical by 3.7% in the first quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock worth $757,489,000 after purchasing an additional 58,587 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. Raymond James Financial reiterated an “outperform” rating and issued a $480.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, August 21st. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Evercore set a $430.00 price target on Intuitive Surgical in a report on Monday, July 6th. Finally, Barclays reiterated an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $445.88 on Wednesday. The company’s fifty day moving average price is $398.31 and its 200-day moving average price is $436.15. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter last year, the business posted $2.40 EPS. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of Intuitive Surgical stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director directly owned 251 shares of the company’s stock, valued at approximately $95,129. This trade represents a 61.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 38,684 shares of company stock valued at $16,770,301 in the last three months. 0.60% of the stock is owned by corporate insiders.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly constructive: the average brokerage recommendation is equivalent to a Buy, while the reported consensus price target of $493.54 is above recent trading levels. However, the article cautions that sell-side ratings can be overly optimistic. Wall Street bullish views on ISRG
• Positive Sentiment: Analysts have been raising earnings estimates, and Zacks highlighted ISRG’s growth profile. The company’s latest quarterly results provide fundamental support, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share versus a $2.65 consensus estimate. Higher earnings estimates
• Neutral Sentiment: ISRG is attracting substantial investor attention, which may increase trading activity but does not necessarily signal a change in business fundamentals. Reported short interest of zero shares and a zero-day days-to-cover ratio also appear inconsistent with the description of a significant increase, limiting the data’s usefulness. ISRG trending-stock analysis
• Negative Sentiment: Several insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold approximately $9.1 million, while a vice president, senior vice president and another director also reduced their holdings. Although planned sales are not necessarily bearish, the cluster may weigh on sentiment. ISRG insider selling
• Negative Sentiment: Valuation remains a key risk. ISRG trades at roughly 54 times earnings and a PEG ratio above 3, leaving limited room for execution disappointments. The stock’s decline below its 200-day moving average may also indicate near-term technical weakness.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.